Combined chemotherapy and ALA-based photodynamic therapy in leukemic murine cells

Leukemia Research

Volumn 36, Issue 9, 2012, Pages 1179-1184

  Diez, Berenice ^a   Ernst, Glenda ^b   Teijo, María Julieta ^a   Batlle, Alcira ^a   Hajos, Silvia ^b   Fukuda, Haydée ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

Author keywords

5 Aminolevulinic acid; Combined therapy; Leukemic cells; Multidrug resistance; Photodynamic therapy

Indexed keywords

AMINOLEVULINIC ACID; DOXORUBICIN; SUPEROXIDE; VINCRISTINE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CELL MEMBRANE; CELL SURVIVAL; CELL VIABILITY; CHEMOSENSITIVITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; LEUKEMIA CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; NONHUMAN; OXIDATIVE STRESS; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL;

AMINOLEVULINIC ACID; ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; CELL DEATH; CELL LINE, TUMOR; COMBINED MODALITY THERAPY; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; LEUKEMIA; MICE; NECROSIS; OXIDATIVE STRESS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; VINCRISTINE;

EID: 84864012160     PISSN: 01452126     EISSN: 18735835     Source Type: Journal    
DOI: 10.1016/j.leukres.2012.04.027     Document Type: Article

References (37)

1. Hale G.A., Tong X., Benaim E., Cunningham J.M., Heslop H.E., Horwiz E.M., et al. Allogeneic bone marrow transplantation in children failing prior autologous bone marrow transplantation. Bone Marrow Transplant 2001, 27(2):155-162.
2. Lie A.K., Au W.Y., Liang R. Haematopoietic stem cell transplantation in Hong Kong. Hong Kong Med J 2009, 15(3 Suppl. 3):17-21.
3. Schultz F.W., Martens A.C.M., Hagenbeek A. The contribution of residual leukemia cells in the graft to leukemia relapse after autologous bone marrow transplantation: mathematical considerations. Leukemia 1989, 3(7):530-534.
4. Imrie K., Dicke K.A., Keating A. Autologous bone marrow transplantation for acute myeloid leukemia. Stem Cells 1996, 14(1):69-78. [Review].
5. Devetten M., Armitage J.O. Hematopoietic cell transplantation: progress and obstacles. Ann Oncol 2007, 18(9):1450-1456. [Review].
6. Houtenbos I., Bracho F., Davenport V., Slack R., van de Ven C., Suen Y., et al. Autologous bone marrow transplantation for childhood acute lymphoblastic leukemia: a novel combined approach consisting of ex vivo marrow purging, modulation of multi-drug resistance, induction of autograft vs. leukemia effect, and post-transplant immuno- and chemo-therapy (PTIC). Bone Marrow Transplant 2001, 27(2):145-153.
7. Agostinis P., Berg K., Cengel K.A., Foster T.H., Girotti A.W., Gollnick S.O., et al. Photodynamic therapy of cancer: an update. CA Cancer J Clin 2011, 61(4):250-281.
8. Triesscheijn M., Baas P., Schellens J.H., Stewart F.A. Photodynamic therapy in oncology. Oncologist 2006, 11(9):1034-1044.
9. Krammer B., Plaetzer K. ALA and its clinical impact, from bench to bedside. Photochem Photobiol Sci 2008, 7(3):283-289. [Review].
10. Li W., Zhang W.J., Ohnishi K., Yamada I., Ohno R., Hashimoto K. 5-Aminolaevulinic acid-mediated photodynamic therapy in multidrug resistant leukemia cells. J Photochem Photobiol B 2001, 60(2-3):79-86.
11. Zimmermann A., Walt H., Haller U., Baas P., Klein S.D. Effects of chlorin-mediated photodynamic therapy combined with fluoropyrimidines in vitro and in a patient. Cancer Chemother Pharmacol 2003, 51(2):147-154.
12. Xie Q., Jia L., Liu Y.H., Wei C.G. Synergetic anticancer effect of combined gemcitabine and photodynamic therapy on pancreatic cancer in vivo. World J Gastroenterol 2009, 15(6):737-741.
13. Lopez E.L., Scolnik M., Alvarez E., Hajos E. Modulatory activity of PSC 833 snd cyclosporin-A in vincristine and doxorubicin-selected multidrug resistant murine leukemic cells. Leuk Res 2001, 25:85-93.
14. Merlin J.L., Azzi S., Lignon D., Ramacci C., Zeghari N., Guillemin F. MTT assays allow quick and reliable measurement of the response of human tumour cells to photodynamic therapy. Eur J Cancer 1992, 28:1452-1458.
15. García M.G., Alaniz L., Lopes E.C., Blanco G., Hajos S.E., Alvarez E. Inhibition of NF-kappaB activity by BAY 11-7082 increases apoptosis in multidrug resistant leukemic T-cell lines. Leuk Res 2005, 29(12):1425-1434.
16. Luksiene Z., Eggen I., Moan J., Nesland J.M., Peng Q. Evaluation of protoporphyrin IX production, phototoxicity and cell death pathway induced by hexylester of 5-aminolevulinic acid in Reh and HPB-ALL cells. Cancer Lett 2001, 169(1):33-39.
17. Paz M.L., González Maglio D.H., Weill F.S., Bustamante J., Leoni J. Mitochondrial dysfunction and cellular stress progression after ultraviolet B irradiation in human keratinocytes. Photodermatol Photoimmunol Photomed 2008, 24(3):115-122.
18. Diez B., Cordo Russo R., Teijo M.J., Hajos S., Batlle A., Fukuda H. Ros production by endogenously generated Protoporphyrin IX in murine leukemia cells. Cell Mol Biol (Noisy-le-grand) 2009, 55(2):15-19.
19. Carter W.0., Narayanan P.K., Robinson J.P. Intracellular hydrogen peroxide and superoxide anion detection in endothelial cells. J Leukoc Biol 1994, 55:253-258.
20. Gorin N.C., Aegerter P., Auvert B., Meloni G., Goldstone A.H., Burnett A., et al. Autologous bone marrow transplantation for acute myelocytic leukemia in first remission: a European survey of the role of marrow purging. Blood 1990, 75:1606-1614.
21. Peters W., Hamm C., Baynes R. Principles of bone marrow transplantation. Cancer Medicine 2000, 18 (67):890-910. Hamilton (ON) BC Decker. 5th edition.
22. Cutts S.M., Swift L.P., Rephaeli A., Nudelman A., Phillips D.R. Recent advances in understanding and exploiting the activation of anthracyclines by formaldehyde. Curr Med Chem Anti-Cancer Agents 2005, 5:431-447.
23. Meininger V., Binet S., Chaineau E., Fellous A. In situ response to vinka alkaloids by microtubules in cultured post-implanted mouse embryos. Biol Cell 1990, 68(1):21-29.
24. Casas A., Fukuda H., Riley P.A., Batlle A.M., Del C. Enhancement of aminolevulinic acid based photodynamic therapy by adriamycin. Cancer Lett 1997, 121:105-113.
25. Casas A., Fukuda H., Batlle A.M. del C. Potentiation of the 5-aminolevulinic acid-based photodynamic therapy with cyclophosphamide. Cancer Biochem Biophys 1998, 16:183-196.
26. Sinha A.K., Anand S., Ortel B.J., Chang Y., Mai Z., Hasan T., et al. Methotrexate used in combination with aminolaevulinic acid for photodynamic killing of prostate cancer cells. Br J Cancer 2006, 95(4):485-495.
27. Peterson C.M., Shiah J.G., Sun Y., Kopecková P., Minko T., Straight R.C., et al. HPMA copolymer delivery of chemotherapy and photodynamic therapy in ovarian cancer. Adv Exp Med Biol 2003, 519:101-123.
28. Snyder J.W., Greco W.R., Bellnier D.A., Vaughan L., Henderson B.W. Photodynamic therapy: a means to enhanced drug delivery to tumors. Cancer Res 2003, 63(23):8126-8131.
29. Kirveliene V., Grazeliene G., Dabkeviciene D., Micke I., Kirvelis D., Juodka B., et al. Schedule-dependent interaction between Doxorubicin and mTHPC-mediated photodynamic therapy in murine hepatoma in vitro and in vivo. Cancer Chemother Pharmacol 2006, 57(1):65-72.
30. Dai D.J., Lu C.D., Guo J.M., Zhang J. Effect of inhibiting survivin expression with antisense oligodeoxynucleotides on sensitivity of hepatocellular carcinoma cell lines HepG2 and HepG2/ADM to adriamycin. Ai Zheng 2005, 24(8):951-957.
31. Azuhata T., Scott D., Griffith T.S., Miller M., Sandler A.D. Survivin inhibits apoptosis induced by TRAIL, and the ratio between survivin and TRAIL receptors is predictive of recurrent disease in neuroblastoma. J Pediatr Surg 2006, 41(8):1431-1440.
32. Cogno I.S., Rumie Vittar N.B., Rivarola V. Optimization of photodynamic therapy response by survivin gene knockdown in human metastatic T47D cancer cells. J Photochem Photobiol B 2011, 104(3):434-443.
33. Chang Q., Liu Z.R., Wang D.Y., Kumar M., Chen Y.B., Qin R.Y. Survivin expression induced by doxorubicin in cholangiocarcinoma. World J Gastroenterol 2004, 10(3):415-418.
34. Capella M.A., Capella L.S. A light in multidrug resistance: photodynamic treatment of multidrug-resistant tumors. J Biomed Sci 2003, 10(4):361-366. [Review].
35. Teiten M.H., Bezdetnaya L., Merlin J.L., Bour-Dill C., Pauly M.E., Dicato M., et al. Effect of meta-tetra(hydroxyphenyl)chlorin (mTHPC)-mediated photodynamic therapy on sensitive and multidrug-resistant human breast cancer cells. J Photochem Photobiol B 2001, 62(3):146-152.
36. Tsai T., Hong R.L., Tsai J.C., Lou P.J., Ling I.F., Chen C.T. Effect of 5-aminolevulinic acid-mediated photodynamic therapy on MCF-7 and MCF-7/ADR cells. Lasers Surg Med 2004, 34(1):62-72.
37. Feuerstein T., Berkovitch-Luria G., Nudelman A., Rephaeli A., Malik Z. Modulating ALA-PDT efficacy of mutlidrug resistant MCF-7 breast cancer cells using ALA prodrug. Photochem Photobiol Sci 2011, 10(12):1926-1933.